Longevity research has propelled the scientific community to concentrate on interventions that do more than simply add years to life ...

Q4 2024 Earnings Conference Call March 4, 2025 8:00 AM ETCompany ParticipantsCourtney Dugan - Head-IRMichael Rossi ...

summarized the role of extracellular vesicles containing ectonucleotidases and other purine-metabolizing enzymes involved in purinergic signaling. An original article by Zubiar et al. focused on the ...

Alexa Fluor®-700 anti-mouse CD38 antibody was obtained from eBioscience (San Diego ... Insulin in serum was performed by enzyme-linked immunosorbent assay (ELISA) (RayBiotech, Norcross, GA, United ...

Johnson & Johnson is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the latter company to discontinue development of the program. Back in 2019 ...

Johnson & Johnson has decided that it will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38 Genmab will not pursue further clinical ...

While the initial HexaBody-CD38 clinical data is promising and showed robust clinical efficacy, following a thorough evaluation of the data, the market landscape, and Genmab’s rigorous portfolio ...

Johnson & Johnson has decided that it will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38 Genmab will not pursue further clinical ...